Nobusawa E, Nakajima K
Institute of Medical Science, University of Tokyo, Japan.
Virology. 1988 Nov;167(1):8-14. doi: 10.1016/0042-6822(88)90048-7.
The receptor binding site of the hemagglutinin (HA) molecule of type A influenza virus A/USSR/90/77 (H1N1) has been studied. Site-specific mutagenesis has been used to introduce base changes into the sequence that codes for the amino acid residue at position 226 on the HA molecule, and mutant sequences replaced the wild-type sequence of the HA gene of the SV40-HA recombinant virus (SVHA). Mutant HA proteins were expressed in African green monkey kidney cells and analyzed for receptor binding and fusion activities. Two mutant HA proteins containing single amino acid substitutions of Asn and Met for Gln at position 226 retained their receptor binding activity, but others with amino acid substitutions Glu, His, Leu, Val, and Thr for Gln at position 226 lost this activity. All the mutant proteins retained their fusion activity. On the other hand, another four mutants containing single amino acid substitutions at positions other than 226 retained the receptor binding and fusion activities, despite the drastic change in charge or polarity to the respective amino acids. These results suggest that amino acid residue 226 of the H1 subtype of HA is critical for receptor binding activity of the HA protein. Our results also show that the lack of receptor binding activity of the HA protein does not affect fusion activity.
对甲型流感病毒A/USSR/90/77(H1N1)血凝素(HA)分子的受体结合位点进行了研究。采用位点特异性诱变技术,将碱基变化引入编码HA分子第226位氨基酸残基的序列中,突变序列取代了SV40-HA重组病毒(SVHA)HA基因的野生型序列。突变型HA蛋白在非洲绿猴肾细胞中表达,并分析其受体结合和融合活性。在第226位含有将谷氨酰胺替换为天冬酰胺和甲硫氨酸的单个氨基酸取代的两种突变型HA蛋白保留了其受体结合活性,但其他在第226位含有将谷氨酰胺替换为谷氨酸、组氨酸、亮氨酸、缬氨酸和苏氨酸的氨基酸取代的突变型HA蛋白失去了这种活性。所有突变蛋白均保留了其融合活性。另一方面,另外四个在第226位以外位置含有单个氨基酸取代的突变体,尽管各自氨基酸的电荷或极性发生了剧烈变化,但仍保留了受体结合和融合活性。这些结果表明,HA H1亚型的第226位氨基酸残基对HA蛋白的受体结合活性至关重要。我们的结果还表明,HA蛋白缺乏受体结合活性并不影响融合活性。